INSL3 and ovarian dysfunction: Notably, Chendi Zhu et al. revealed that insulin-like 3 (INSL3), produced by theca interna cells, continuously decreased with the progress of ovarian insufficiency, which indicates that circulating INSL3 could serve as a promising theca-cell biomarker for POI19.